Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Faricimab for Chronic Central Serous Chorioretinopathy
NCT07681167Phase 2Not yet recruiting
- Sponsor
- Singapore National Eye Centre
- Start
- Dec 2026
- Primary completion
- Aug 2029
01
Overview
A Phase 2 trial of faricimab in Central Serous Chorioretinopathy (CSCR), sponsored by Singapore National Eye Centre. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
faricimab
03
Conditions
Central Serous Chorioretinopathy (CSCR)
Beyond the preview
Go deeper on NCT07681167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07681167.